primary%20biliary%20cirrhosis
PRIMARY BILIARY CIRRHOSIS

Primary biliary cirrhosis is chronic, progressive, autoimmune, cholestatic liver disease more common in middle-aged women. It is characterized by destruction of small to medium bile ducts, leading to cholestasis and frequently, end-stage liver disease.
Diagnostic features are chronic biochemical cholestasis, presence of antimitochondrial antibodies and the characteristic liver biopsy findings.
At present, the diagnosis is most often made in an asymptomatic patient who presents with abnormal lab results on a routine checkup or as part of workup for an associated illness.


 

Introduction

  • Primary biliary cirrhosis (PBC) is an autoimmune disease of a chronic & progressive nature, characterized by destruction of small to medium bile ducts, leading to cholestasis & frequently, end-stage liver disease
    • Diagnostic features of primary biliary cirrhosis (PBC) are the chronic biochemical cholestasis, presence of antimitochondrial antibodies (AMA) & the characteristic liver biopsy findings
  • Suggested to have environmental &/or genetic factors affecting its development
  •  Primary biliary cirrhosis (PBC) is more common in Northern Europeans & the majority of the patients are middle-aged women
    •  Men w/ the disease are more likely to develop hepatocellular carcinoma (HCC)

Signs and Symptoms

Patients may Present w/ Symptoms Attributable to Liver Disease

Fatigue

  • Seen in 20-85% of patients
  • Associated w/ depression, obsessive-compulsive disorder & sleep disturbances
  • Symptom does not correlate w/ severity of liver disease

Pruritus

  • Prevalence rate is 20-75% in patients w/ primary biliary cirrhosis (PBC) 
  • A circadian rhythm may be noted in pruritus due to cholestasis
  • May be so severe as to cause severe emotional disturbance
  • May be present even in patients w/ good liver function
  • Declines in severity w/ time from diagnosis

Jaundice

  • Present in 10-60% of patients due to cholestasis

Right Upper Quadrant Pain

  • Occurs in 8-17% of patients
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
06 Dec 2018
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
Pearl Toh, 22 hours ago
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
6 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
4 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.